Below is a detailed analysis of the quarterly data for Akzo Nobel India Ltd based on the most recent figures (Dec 2024) and their trends compared to the previous period:
For Sales, as of Dec 2024, the value is 1,050.00 Cr.. The value appears strong and on an upward trend. It has increased from 982.00 Cr. (Sep 2024) to 1,050.00 Cr., marking an increase of 68.00 Cr..
For Expenses, as of Dec 2024, the value is 884.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 836.00 Cr. (Sep 2024) to 884.00 Cr., marking an increase of 48.00 Cr..
For Operating Profit, as of Dec 2024, the value is 167.00 Cr.. The value appears strong and on an upward trend. It has increased from 146.00 Cr. (Sep 2024) to 167.00 Cr., marking an increase of 21.00 Cr..
For OPM %, as of Dec 2024, the value is 16.00%. The value appears strong and on an upward trend. It has increased from 15.00% (Sep 2024) to 16.00%, marking an increase of 1.00%.
For Other Income, as of Dec 2024, the value is 6.00 Cr.. The value appears to be declining and may need further review. It has decreased from 9.00 Cr. (Sep 2024) to 6.00 Cr., marking a decrease of 3.00 Cr..
For Interest, as of Dec 2024, the value is 3.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 2.00 Cr. (Sep 2024) to 3.00 Cr., marking an increase of 1.00 Cr..
For Depreciation, as of Dec 2024, the value is 23.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 22.00 Cr. (Sep 2024) to 23.00 Cr., marking an increase of 1.00 Cr..
For Profit before tax, as of Dec 2024, the value is 146.00 Cr.. The value appears strong and on an upward trend. It has increased from 132.00 Cr. (Sep 2024) to 146.00 Cr., marking an increase of 14.00 Cr..
For Tax %, as of Dec 2024, the value is 26.00%. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 26.00%.
For Net Profit, as of Dec 2024, the value is 109.00 Cr.. The value appears strong and on an upward trend. It has increased from 98.00 Cr. (Sep 2024) to 109.00 Cr., marking an increase of 11.00 Cr..
For EPS in Rs, as of Dec 2024, the value is 23.85. The value appears strong and on an upward trend. It has increased from 21.50 (Sep 2024) to 23.85, marking an increase of 2.35.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
×
Quarterly Chart
Profit & Loss - Annual Report
Last Updated: May 15, 2025, 7:21 am
Metric
Mar 2014
Mar 2015
Mar 2016
Mar 2017
Mar 2018
Mar 2019
Mar 2020
Mar 2021
Mar 2022
Mar 2023
Mar 2024
Mar 2025
Sales
2,332
2,442
2,640
2,572
2,719
2,918
2,662
2,421
3,149
3,802
3,962
4,091
Expenses
2,141
2,181
2,380
2,244
2,420
2,576
2,291
2,078
2,714
3,276
3,328
3,450
Operating Profit
192
261
260
329
300
342
370
343
434
526
633
641
OPM %
8%
11%
10%
13%
11%
12%
14%
14%
14%
14%
16%
16%
Other Income
57
68
110
65
240
43
41
21
23
26
35
28
Interest
2
2
2
3
4
4
9
10
14
14
12
10
Depreciation
44
53
54
54
58
65
79
76
76
82
82
89
Profit before tax
203
275
314
337
478
316
323
278
367
456
573
570
Tax %
26%
32%
32%
27%
16%
33%
27%
25%
21%
26%
26%
25%
Net Profit
150
186
214
247
401
211
237
208
290
335
427
429
EPS in Rs
32.19
39.93
45.91
52.94
85.85
46.33
52.13
45.59
63.68
73.58
93.70
94.11
Dividend Payout %
233%
50%
153%
42%
26%
52%
27%
110%
118%
88%
80%
106%
×
Profit & Loss Yearly Chart
YoY Net Profit Growth
Year
2014-2015
2015-2016
2016-2017
2017-2018
2018-2019
2019-2020
2020-2021
2021-2022
2022-2023
2023-2024
2024-2025
YoY Net Profit Growth (%)
24.00%
15.05%
15.42%
62.35%
-47.38%
12.32%
-12.24%
39.42%
15.52%
27.46%
0.47%
Change in YoY Net Profit Growth (%)
0.00%
-8.95%
0.37%
46.93%
-109.73%
59.70%
-24.56%
51.66%
-23.91%
11.95%
-26.99%
Akzo Nobel India Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
Compounded Sales Growth
10 Years:
5%
5 Years:
9%
3 Years:
9%
TTM:
3%
Compounded Profit Growth
10 Years:
11%
5 Years:
13%
3 Years:
14%
TTM:
0%
Stock Price CAGR
10 Years:
10%
5 Years:
12%
3 Years:
22%
1 Year:
15%
Return on Equity
10 Years:
24%
5 Years:
26%
3 Years:
30%
Last Year:
32%
Last Updated: Unknown
No data available for the Balance Sheet data table.
After reviewing the key financial ratios for Akzo Nobel India Ltd, here is a detailed analysis based on the latest available data and recent trends:
For FaceValue, as of Mar 24, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 10.00.
For Basic EPS (Rs.), as of Mar 24, the value is 93.68. This value is within the healthy range. It has increased from 73.58 (Mar 23) to 93.68, marking an increase of 20.10.
For Diluted EPS (Rs.), as of Mar 24, the value is 93.68. This value is within the healthy range. It has increased from 73.58 (Mar 23) to 93.68, marking an increase of 20.10.
For Cash EPS (Rs.), as of Mar 24, the value is 111.85. This value is within the healthy range. It has increased from 91.78 (Mar 23) to 111.85, marking an increase of 20.07.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 292.02. It has increased from 289.03 (Mar 23) to 292.02, marking an increase of 2.99.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 292.29. It has increased from 289.30 (Mar 23) to 292.29, marking an increase of 2.99.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 870.68. It has increased from 835.63 (Mar 23) to 870.68, marking an increase of 35.05.
For PBDIT / Share (Rs.), as of Mar 24, the value is 146.77. This value is within the healthy range. It has increased from 121.43 (Mar 23) to 146.77, marking an increase of 25.34.
For PBIT / Share (Rs.), as of Mar 24, the value is 128.68. This value is within the healthy range. It has increased from 103.30 (Mar 23) to 128.68, marking an increase of 25.38.
For PBT / Share (Rs.), as of Mar 24, the value is 125.93. This value is within the healthy range. It has increased from 100.20 (Mar 23) to 125.93, marking an increase of 25.73.
For Net Profit / Share (Rs.), as of Mar 24, the value is 93.76. This value is within the healthy range. It has increased from 73.65 (Mar 23) to 93.76, marking an increase of 20.11.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 93.76. This value is within the healthy range. It has increased from 73.65 (Mar 23) to 93.76, marking an increase of 20.11.
For PBDIT Margin (%), as of Mar 24, the value is 16.85. This value is within the healthy range. It has increased from 14.53 (Mar 23) to 16.85, marking an increase of 2.32.
For PBIT Margin (%), as of Mar 24, the value is 14.77. This value is within the healthy range. It has increased from 12.36 (Mar 23) to 14.77, marking an increase of 2.41.
For PBT Margin (%), as of Mar 24, the value is 14.46. This value is within the healthy range. It has increased from 11.99 (Mar 23) to 14.46, marking an increase of 2.47.
For Net Profit Margin (%), as of Mar 24, the value is 10.76. This value exceeds the healthy maximum of 10. It has increased from 8.81 (Mar 23) to 10.76, marking an increase of 1.95.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 10.76. This value is within the healthy range. It has increased from 8.81 (Mar 23) to 10.76, marking an increase of 1.95.
For Return on Networth / Equity (%), as of Mar 24, the value is 32.10. This value is within the healthy range. It has increased from 25.48 (Mar 23) to 32.10, marking an increase of 6.62.
For Return on Capital Employeed (%), as of Mar 24, the value is 39.55. This value is within the healthy range. It has increased from 31.82 (Mar 23) to 39.55, marking an increase of 7.73.
For Return On Assets (%), as of Mar 24, the value is 14.69. This value is within the healthy range. It has increased from 12.22 (Mar 23) to 14.69, marking an increase of 2.47.
For Asset Turnover Ratio (%), as of Mar 24, the value is 1.40. It has decreased from 1.43 (Mar 23) to 1.40, marking a decrease of 0.03.
For Current Ratio (X), as of Mar 24, the value is 1.35. This value is below the healthy minimum of 1.5. It has decreased from 1.48 (Mar 23) to 1.35, marking a decrease of 0.13.
For Quick Ratio (X), as of Mar 24, the value is 0.92. This value is below the healthy minimum of 1. It has decreased from 1.00 (Mar 23) to 0.92, marking a decrease of 0.08.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 3.32. This value is below the healthy minimum of 4. It has increased from 3.30 (Mar 23) to 3.32, marking an increase of 0.02.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 96.08. This value exceeds the healthy maximum of 50. It has increased from 81.52 (Mar 23) to 96.08, marking an increase of 14.56.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 80.54. This value exceeds the healthy maximum of 50. It has increased from 65.42 (Mar 23) to 80.54, marking an increase of 15.12.
For Earning Retention Ratio (%), as of Mar 24, the value is 3.92. This value is below the healthy minimum of 40. It has decreased from 18.48 (Mar 23) to 3.92, marking a decrease of 14.56.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 19.46. This value is below the healthy minimum of 40. It has decreased from 34.58 (Mar 23) to 19.46, marking a decrease of 15.12.
For Interest Coverage Ratio (X), as of Mar 24, the value is 53.42. This value is within the healthy range. It has increased from 39.18 (Mar 23) to 53.42, marking an increase of 14.24.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 35.13. This value is within the healthy range. It has increased from 24.77 (Mar 23) to 35.13, marking an increase of 10.36.
For Enterprise Value (Cr.), as of Mar 24, the value is 10,323.76. It has increased from 9,851.79 (Mar 23) to 10,323.76, marking an increase of 471.97.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 2.61. This value is within the healthy range. It has increased from 2.59 (Mar 23) to 2.61, marking an increase of 0.02.
For EV / EBITDA (X), as of Mar 24, the value is 15.46. This value exceeds the healthy maximum of 15. It has decreased from 17.83 (Mar 23) to 15.46, marking a decrease of 2.37.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.74. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.74.
For Retention Ratios (%), as of Mar 24, the value is 3.91. This value is below the healthy minimum of 30. It has decreased from 18.47 (Mar 23) to 3.91, marking a decrease of 14.56.
For Price / BV (X), as of Mar 24, the value is 8.16. This value exceeds the healthy maximum of 3. It has increased from 7.92 (Mar 23) to 8.16, marking an increase of 0.24.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.74. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.74.
For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.03.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
×
Profitability Ratios (%)
Liquidity Ratios
Liquidity Ratios (%)
Interest Coverage Ratios (%)
Valuation Ratios
Fair Value
Fair Value of Akzo Nobel India Ltd as of June 13, 2025 is: 2,675.25
Calculation basis:
Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.
As of June 13, 2025, Akzo Nobel India Ltd is Overvalued by 17.38% compared to the current share price 3,238.00
Intrinsic Value of Akzo Nobel India Ltd as of June 13, 2025 is: 3,092.56
Calculation basis:
Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.
This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.
As of June 13, 2025, Akzo Nobel India Ltd is Overvalued by 4.49% compared to the current share price 3,238.00
Last 5 Year EPS CAGR: 15.60%
*Investments are subject to market risks
Strength and Weakness
Unable to fetch valid data for stock valuation.
Stock Analysis
Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Akzo Nobel India Ltd:
Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
ROE%: 32.1% (Industry Average ROE: 20.11%)
ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
Stock P/E: 34.5 (Industry average Stock P/E: 36.97)
Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
Total Debt / Equity: 0
Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions. Stock Rating:
About the Company - Qualitative Analysis
Akzo Nobel India Ltd. is a Public Limited Listed company incorporated on 12/03/1954 and has its registered office in the State of West Bengal, India. Company's Corporate Identification Number(CIN) is L24292WB1954PLC021516 and registration number is 021516. Currently Company is involved in the business activities of Manufacture of paints and varnishes, enamels or lacquers. Company's Total Operating Revenue is Rs. 4091.20 Cr. and Equity Capital is Rs. 45.50 Cr. for the Year ended 31/03/2025.
FAQ: Stock data is invalid or not in the correct format.
Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Akzo Nobel India Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE
